Neihu Dist, Taipei
Antibody manufacturer, more than 70,000 antibodies catalogued, with a capacity for generating 300 mouse monoclonal antibodies and 200 rabbit polyclonal antibodies per month.
Cancer molecular information service company. Aims to provide comprehensive tumor genomic profiling and generate actionable report to identify the right treatment for cancer treatment, and to enable improved resolution for tumor stratification, therapeutic response studies, and identification of potential biomarkers for companion diagnostics.
Cord blood banking service under the ‘Babybanks’ brand. Also offers Umbilical Cord Mesenchymal Stem Cell banking, Dental Pulp Stem Cell banking, Stem Cell Revitalizer for cosmetology, along with early-stage genetic diagnosis for Spinal Muscular Atrophy (SMA), serum-based screening for Down Syndrome, and Pre-Implantation Genetic Diagnosis.
Covers the entire pharmaceutical supply chain from research and development to sales and distribution. Provides outsourced R&D and manufacturing services for domestic and multinational pharmaceutical companies. PIC/S certified.
Virtually operating company, focusing on developing new drugs in various areas including oncology and infectious disease. Focusing on translational medicine stage of drug development, team surveys many small molecules, peptides, biologics, and platform technologies at the lead optimization stage. Projects are brought into BRIM through co-development partnerships or in-licensing deals, and development of the projects is conducted at global CROs and CMOs that fit the needs of the project. Once clinical proof of concept (POC) is reached, the projects are partnered out for further clinical development.
API manufacture for small and large molecule drugs.
Facilities consist of seven areas for fermentation, purification and chemical synthesis for production ranging from kilograms to multiple tons. Fermentation capacity ranges from 75L to 50,000L. Purification and synthesis ranging from 30L to 8,000L.
Subsidiary of China Chemical & Pharmaceutical Co., Ltd.
Contract development and manufacturing organization (CMO) providing development, analytical testing, and cGMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing.
Contract development and manufacturing organization (CDMO) with a particular focus on biologicals, providing the following services:
1. Process development of peptide or protein APIs from microbial or human recombinant fermentation processes
2. Formulation development of biological injectables
3. Manufacturing of biological APIs, lyophilized injectables, and prefilled syringes/cartridges for preclinical, clinical, and commercial uses (fill and finish)